• Home
  • Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.

Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.

Author List
Faden DL, Algazi A
Publication
Journal of the National Cancer Institute
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1205242
Publication Year
2016
PubMed ID
27671684
Publication Title
Faden DL, Algazi A. Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma. J Natl Cancer Inst. 2017 01; 109(1).